Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Mcl-1 inhibitor
AMPK activator.
Peptide, GnRH analog.
Recombinant HIV-1 multi-epitope chimeric antige...
Curcumin derivative; DNMT1 and α-amylase inhib...
Cationic antimicrobial peptide, alters bacteria...
PAK inhibitor.Smo inhibitor.
Organosulfur found in garlic.
Endogenous neuropeptide, also known as substanc...
Steroid lactone produced by Withania somnifera;...
ACE inhibitor.
Tricyclic antidepressant; potential D1/2 antago...
SERT inhibitor, potential voltage-gated K+ chan...
Tamoxifen analog; SERM.
Negative control for PKC activation.
Galactose analog, allolactose mimic, induces ac...
H+/K+ ATPase and ROCK-2 inhibitor.
CysLT1 antagonist.
ITC found in cruciferous vegetables; HDAC inhib...
Endogenous secondary bile acid.